Vitamin D and inflammatory bowel disease

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Ardesia, Marco ^a   Ferlazzo, Guido ^b   Fries, Walter ^a   Sebekova K ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

^c Clinical Unit for Chronic Bowel Disorders IBD UNIT Department of Clinical and Experimental Medicine University of Messina ^*

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR;

CELL ACTIVATION; CROHN DISEASE; DIETARY INTAKE; EX VIVO STUDY; EXPERIMENTAL ANIMAL; GENETIC ASSOCIATION; GENETIC VARIABILITY; GROWTH RETARDATION; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; MULTICENTER STUDY (TOPIC); NONHUMAN; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUN EXPOSURE; ULTRAVIOLET RADIATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WEIGHT REDUCTION; ANIMAL; BLOOD; GENETICS; IMMUNITY; INFLAMMATORY BOWEL DISEASES; TREATMENT OUTCOME;

ANIMALIA;

ANIMALS; HUMANS; IMMUNITY; INFLAMMATORY BOWEL DISEASES; RECEPTORS, CALCITRIOL; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84929378548     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/470805     Document Type: Review

References (109)

1. G. Jones, S. A. Strugnell, and H. F. DeLuca, "Current understanding of the molecular actions of vitamin D, " Physiological Reviews, vol. 78, no. 4, pp. 1193-1231, 1998.
2. N. Narula and J. K. Marshall, "Management of inflammatory bowel disease with vitamin D: beyond bone health, " Journal of Crohn's & Colitis, vol. 6, no. 4, pp. 397-404, 2012.
3. M. F. Holick, T. C. Chen, Z. Lu, and E. Sauter, "Vitamin D and skin physiology: aD-lightful story, " Journal of Bone andMineral Research, vol. 22, no. 2, pp.V28-V33, 2007.
4. F. Baeke, E. V. Etten, C. Gysemans, L. Overbergh, and C. Mathieu, "Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities, " Molecular Aspects of Medicine, vol. 29, no. 6, pp. 376-387, 2008.
5. J. W. Pike and M. B. Meyer, "The vitamin D receptor: new paradigms for the regulation of gene expression by 1, 25-dihydroxyvitamin D3, " Rheumatic Disease Clinics of North America, vol. 38, no. 1, pp. 13-27, 2012.
6. M. Raman, A. N. Milestone, J. R. F. Walters, A. L. Har, and S. Ghosh, "Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer, " Therapeutic Advances in Gastroenterology, vol. 4, no. 1, pp. 49-62, 2011.
7. R. F. Chun, P. T. Liu, R. L.Modlin, J. S. Adams, andM.Hewison, "Impact of vitamin D on immune function: lessons learned from genome-wide analysis, " Frontiers in Physiology, vol. 5, article 151, 15 pages, 2014.
8. J. Sun, "Vitamin D and mucosal immune function, " Current Opinion in Gastroenterology, vol. 26, no. 6, pp. 591-595, 2010.
9. J. Chen, D. Bruce, and M. T. Cantorna, "Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation, " BMC Immunology, vol. 15, no. 6, pp. 1-11, 2014.
10. H.Kühne, A. Schutkowski, S.Weinholz et al., "VitaminDreceptor regulates intestinal proteins involved in cell proliferation, migration and stress response, " Lipids inHealth andDisease, vol. 13, article 51, 2014.
11. E. van Etten and C. Mathieu, "Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 1-2, pp. 93-101, 2005.
12. J. Tang, R. Zhou, D. Luger et al., "Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response, " Journal of Immunology, vol. 182, no. 8, pp. 4624-4632, 2009.
13. L. E. Jeffery, F. Burke, M. Mura et al., "1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, " Journal of Immunology, vol. 183, no. 9, pp. 5458-5467, 2009.
14. M. R. Haussler, C. A. Haussler, G. K. Whitfield et al., "The nuclear vitamin D receptor controls the expression of genes encoding factors which feed the 'Fountain of Youth' to mediate healthful aging, "The Journal of Steroid Biochemistry andMolecular Biology, vol. 121, no. 1-2, pp. 88-97, 2010.
15. J.N.Artaza, F. Sirad, M. G. Ferrini, and K. C.Norris, "1, 25(OH)2 vitamin D3 inhibits cell proliferation by promoting cell cycle arrest without inducing apoptosis and modifies cell morphology of mesenchymal multipotent cells, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 119, no. 1-2, pp. 73-83, 2010.
16. M. G. Bischof, K. Redlich, C. Schiller et al., "Growth inhibitory effects on human colon adenocarcinoma-derived Caco-2 cells and calcemic potential of 1α, 25-dihydroxyvitamin D3 analogs: structure-function relationships, " Journal of Pharmacology and Experimental Therapeutics, vol. 275, no. 3, pp. 1254-1260, 1995.
17. H. S. Cross, M. Pavelka, J. Slavik, and M. Peterlik, "Growth control of human colon cancer cells by vitamin D and calcium in vitro, " Journal of the National Cancer Institute, vol. 84, no. 17, pp. 1355-1362, 1992.
18. J. P. Hugot, M. Chamaillard, H. Zouali et al., "Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease, " Nature, vol. 411, no. 6837, pp. 599-603, 2001.
19. N. Inohara, Y. Ogura, A. Fontalba et al., "Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease, " The Journal of Biological Chemistry, vol. 278, no. 8, pp. 5509-5512, 2003.
20. T. T. Wang, B. Dabbas, D. Laperriere et al., "Direct and indirect induction by 1, 25-dihydroxyvitamin D3 of theNOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease, "The Journal of Biological Chemistry, vol. 285, no. 4, pp. 2227-2231, 2010.
21. S.Wu, Y. G. Zhang, R. Lu et al., "Intestinal epithelial vitaminD receptor deletion leads to defective autophagy in colitis, " Gut, 2014.
22. M. Verway, M. A. Behr, and J. H. White, "Vitamin D, NOD2, autophagy and Crohn's disease, " Expert Review of Clinical Immunology, vol. 6, no. 4, pp. 505-508, 2010.
23. J. D. Simmons, C. Mullighan, K. I. Welsh, and D. P. Jewell, "Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility, " Gut, vol. 47, no. 2, pp. 211-214, 2000.
24. K. Martin, M. Radlmayr, R. Borchers, M. Heinzlmann, and C. Folwaczny, "Candidate genes colocalized to linkage regions in inflammatory bowel disease, " Digestion, vol. 66, no. 2, pp. 121-126, 2002.
25. K. Köstner, N. Denzer, C. S. L. Müller, R. Klein, W. Tilgen, and J. Reichrath, "The relevance of Vitamin D Receptor (VDR) gene polymorphisms for cancer: a review of the literature, " Anticancer Research, vol. 29, no. 9, pp. 3511-3536, 2009.
26. Y. Xu, B. He, Y. Pan et al., "Systematic review and meta-analysis on vitaminDreceptor polymorphisms and cancer risk, " Tumour Biology, vol. 35, no. 5, pp. 4153-4169, 2014.
27. K. Tizaoui, A. Berraies, B. Hamdi, W. Kaabachi, K. Hamzaoui, and A.Hamzaoui, "Association of vitamin d receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case-control studies, " Lung, vol. 192, no. 6, pp. 955-965, 2014.
28. D. Santoro, D. Caccamo, G. Gagliostro et al., "Vitamin D metabolism and activity as well as genetic variants of the vitamin D receptor (VDR) in chronic kidney disease patients, " Journal of Nephrology, vol. 26, no. 4, pp. 636-644, 2013.
29. D. J. Hughes, R. McManus, P. Neary, C. O'Morain, and M. O'Sullivan, "Common variation in the vitamin D receptor gene and risk of inflammatory bowel disease in an Irish case-control study, " European Journal of Gastroenterology & Hepatology, vol. 23, no. 9, pp. 807-812, 2011.
30. W. Pluskiewicz, J. Zdrzałek, and D. Karasek, "Spine bone mineral density and VDR polymorphism in subjects with ulcerative colitis, " Journal of Bone and Mineral Metabolism, vol. 27, no. 5, pp. 567-573, 2009.
31. F. H. Pei, Y. J. Wang, S. L. Gao et al., "Vitamin D receptor gene polymorphism and ulcerative colitis susceptibility in Han Chinese, " Journal of Digestive Diseases, vol. 12, no. 2, pp. 90-98, 2011.
32. S. L. Xia, L. Q. Yu, H. Chen et al., "Association of vitamin D receptor gene polymorphisms with the susceptibility to ulcerative colitis in patients from Southeast China, " Journal of Receptors and Signal Transduction, 2014.
33. Y. Y. Luo, X. L. Shu, H. Zhao, J. D. Yu, M. Ma, and J. Chen, "Association between vitamin D receptor gene polymorphisms and pediatric Crohn's disease in China: A study based on gene sequencing, " Zhongguo Dang Dai Er Ke Za Zhi, vol. 15, no. 11, pp. 1006-1008, 2013.
34. C. L. Noble, J. McCullough, W. Ho et al., "Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patientswith inflammatory bowel disease, " Alimentary Pharmacology & Therapeutics, vol. 27, no. 7, pp. 588-596, 2008.
35. R. W. Bentley, D. Keown, T. R. Merriman et al., "Vitamin D receptor gene polymorphism associated with inflammatory bowel disease inNewZealandmales, " Alimentary Pharmacology andTherapeutics, vol. 33, no. 7, pp. 855-856, 2011.
36. R. Dresner-Pollak, Z. Ackerman, R. Eliakim, A. Karban, Y. Chowers, andH. H. Fidder, "The BsmI vitamin D receptor gene polymorphism is associated with ulcerative colitis in Jewish Ashkenazi patients, " Genetic Testing, vol. 8, no. 4, pp. 417-420, 2004.
37. N. Naderi, A. Farnood, M. Habibi et al., "Association of vitamin D receptor gene polymorphisms in Iranian patients with inflammatory bowel disease, " Journal of Gastroenterology and Hepatology, vol. 23, no. 12, pp. 1816-1822, 2008.
38. L.-N. Xue, K.-Q.Xu, W. Zhang, Q.Wang, J.Wu, andX.-Y.Wang, "Associations between vitamin D receptor polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a metaanalysis, " Inflammatory Bowel Diseases, vol. 19, no. 1, pp. 54-60, 2013.
39. L. Wang, Z. T. Wang, J. J. Hu, R. Fan, J. Zhou, and J. Zhong, "Polymorphisms of the vitamin D receptor gene and the risk of inflammatory bowel disease: a meta-analysis, " Genetics and Molecular Research, vol. 13, no. 2, pp. 2598-2610, 2014.
40. A. Y.O.M.Carvalho, K. S. Bishop, D. Y.Han et al., "The role of vitamin D level and related single nucleotide polymorphisms in Crohn's disease, " Nutrients, vol. 5, no. 10, pp. 3898-3909, 2013.
41. G. Jones and G. Stewart, "Association of PHF11 polymorphisms with asthma and allergy, " Thorax, vol. 65, no. 7, pp. 659-660, 2010.
42. J. J. Eloranta, C. Wenger, J. Mwinyi et al., "Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease, " Pharmacogenetics and Genomics, vol. 21, no. 9, pp. 559-564, 2011.
43. A. Sonnenberg, H. Ehms, G. E. Sonnenberg, and G. Strohmeyer, "25-Hydroxycholecalciferol serum levels in patients with Crohn's disease, " Acta Hepato-Gastroenterologica, vol. 24, no. 4, pp. 293-295, 1977.
44. T. Nic Suibhne, G. Cox, M. Healy, C. O'Morain, and M. O'Sullivan, "Vitamin D deficiency in Crohn's disease: prevalence, risk factors and supplement use in an outpatient setting, " Journal of Crohn's & Colitis, vol. 6, no. 2, pp. 182-188, 2012.
45. S. Ardizzone, S. Bollani, P. Bettica, M. Bevilacqua, P. Molteni, and G. B. Porro, "Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn's disease and ulcerative colitis, " Journal of InternalMedicine, vol. 247, no. 1, pp. 63-70, 2000.
46. M. Tajika, A. Matsuura, T. Nakamura et al., "Risk factors for vitamin D deficiency in patients with Crohn's disease, " Journal of Gastroenterology, vol. 39, no. 6, pp. 527-533, 2004.
47. M. T. Abreu, Y. Kantorovich, E. A. Vasiliauskas et al., "Measurement of vitaminDlevels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1, 25-dihydroxyvitamin D and low bone mineral density, " Gut, vol. 53, no. 8, pp. 1129-1136, 2004.
48. J. R. de Bruyn, R. van Heeckeren, C. Y. Ponsioen et al., "Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands, " Journal of Crohn's and Colitis, vol. 8, no. 10, pp. 1267-1273, 2014.
49. L. E. Veit, L. Maranda, J. Fong, and B. U. Nwosu, "The vitamin D status in inflammatory bowel disease, " PLoS ONE, vol. 9, no. 7, Article ID e101583, 2014.
50. A. D. Harries, R. Brown, R. V. Heatley, L. A. Williams, S. Woodhead, and J. Rhodes, "VitaminDstatus in Crohn's disease: association with nutrition and disease activity, " Gut, vol. 26, no. 11, pp. 1197-1203, 1985.
51. M. Rudnicki, A. Frølich, and I. Transbøl, "Inappropriate hypercalcitriolemia in ileum-resected patients with Crohn's disease, " Mineral and Electrolyte Metabolism, vol. 18, no. 1, pp. 52-55, 1992.
52. A. J. Joseph, B. George, A. B. Pulimood, M. S. Seshadri, and A. Chacko, "25 (OH) vitamin D level in Crohn's disease: associationwith sun exposure & disease activity, " Indian Journal of Medical Research, vol. 130, no. 2, pp. 133-137, 2009.
53. D. McCarthy, P. Duggan, M. O'Brien et al., "Seasonality of vitamin D status and bone turnover in patients with Crohn's disease, " Alimentary Pharmacology & Therapeutics, vol. 21, no. 9, pp. 1073-1083, 2005.
54. W. El-Matary, S. Sikora, and D. Spady, "Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease, " Digestive Diseases and Sciences, vol. 56, no. 3, pp. 825-829, 2011.
55. J. Silvennoinen, "Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease, " Journal of Internal Medicine, vol. 239, no. 2, pp. 131-137, 1996.
56. J. Gilman, F. Shanahan, and K. D. Cashman, "Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis, " Alimentary Pharmacology & Therapeutics, vol. 23, no. 7, pp. 1007-1016, 2006.
57. H. N. de Souza, F. L. Lora, C. A. M. Kulak, N. C. P. Mañas, H. M. B. Amarante, and V. Z. C. Borba, "Low levels of 25-hydroxyvitamin D (25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density, " Arquivos Brasileiros de Endocrinologia eMetabologia, vol. 52, no. 4, pp. 684-691, 2008.
58. W.D. Leslie, N. Miller, L. Rogala, andC. N. Bernstein, "Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study, " American Journal of Gastroenterology, vol. 103, no. 6, pp. 1451-1459, 2008.
59. A. Ulitsky, A. N. Ananthakrishnan, A. Naik et al., "Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life, " Journal of Parenteral and EnteralNutrition, vol. 35, no. 3, pp. 308-316, 2011.
60. V.Hassan, S.Hassan, P. Seyed-Javad et al., "Association between serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDS) activity, " Medical Journal of Malaysia, vol. 68, no. 1, pp. 34-38, 2013.
61. R. H. Alkhouri, H. Hashmi, R. D. Baker, D. Gelfond, and S. S. Baker, "Vitamin and mineral status in patients with inflammatory bowel disease, " Journal of Pediatric Gastroenterology and Nutrition, vol. 56, no. 1, pp. 89-92, 2013.
62. H. M. Pappa, C. M. Gordon, T. M. Saslowsky et al., "Vitamin D status in children and young adults with inflammatory bowel disease, " Pediatrics, vol. 118, no. 5, pp. 1950-1961, 2006.
63. J. Jahnsen, J. A. Falch, P. Mowinckel, and E. Aadland, "Vitamin D status, parathyroid hormone and bone mineral density in patients with inflammatory bowel disease, " Scandinavian Journal of Gastroenterology, vol. 37, no. 2, pp. 192-199, 2002.
64. A. Kuwabara, K. Tanaka, N. Tsugawa et al., "High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease, "Osteoporosis International, vol. 20, no. 6, pp. 935-942, 2009.
65. Y. Ezzat and K. Hamdy, "The frequency of low bone mineral density and its associated risk factors in patients with inflammatory bowel diseases, " International Journal of Rheumatic Diseases, vol. 13, no. 3, pp. 259-265, 2010.
66. A. Atia, R. Murthy, B. A. Bailey et al., "Vitamin D Status in Veterans with inflammatory bowel disease: relationship to Health care costs and services, " Military Medicine, vol. 176, no. 6, pp. 711-714, 2011.
67. I. Hessov, L. Mosekilde, F. Melsen et al., "Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease, " Scandinavian Journal of Gastroenterology, vol. 19, no. 5, pp. 691-696, 1984.
68. S.Nakajima, H. Iijima, S. Egawa et al., "Association of vitamin K deficiency with bonemetabolism and clinical disease activity in inflammatory bowel disease, " Nutrition, vol. 27, no. 10, pp. 1023-1028, 2011.
69. S. Laakso, H. Valta, M. Verkasalo, S. Toiviainen-Salo, H. Viljakainen, and O. Mäkitie, "Impaired bone health in inflammatory bowel disease: a case-control study in 80 pediatric patients, " Calcified Tissue International, vol. 91, no. 2, pp. 121-130, 2012.
70. R. H. Driscoll Jr., S. C.Meredith, M. Sitrin, and I.H. Rosenberg, "VitaminDdeficiency and bone disease in patients with Crohn's disease, " Gastroenterology, vol. 83, no. 6, pp. 1252-1258, 1982.
71. H. Vogelsang, R. Schöfl, W. Tillinger, P. Ferenci, and A. Gangl, "25-Hydroxyvitamin D absorption in patients with Crohn's disease and with pancreatic insufficiency, " Wiener Klinische Wochenschrift, vol. 109, no. 17, pp. 678-682, 1997.
72. E. J. Schoon, M. C. A. Müller, C. Vermeer, L. J. Schurgers, R.-J. M. Brummer, and R. W. Stockbrügger, "Low serum and bone vitamin K status in patients with longstanding Crohn's disease: another pathogenetic factor of osteoporosis inCrohn's disease?" Gut, vol. 48, no. 4, pp. 473-477, 2001.
73. K. V.Haderslev, P. B. Jeppesen, H. A. Sorensen, P. B.Mortensen, andM. Staun, "Vitamin D status and measurements of markers of bone metabolism in patients with small intestinal resection, " Gut, vol. 52, no. 5, pp. 653-658, 2003.
74. J. Gilman, F. Shanahan, and K. D. Cashman, "Determinants of vitamin D status in adult Crohn's disease patients, with particular emphasis on supplemental vitamin D use, " European Journal of Clinical Nutrition, vol. 60, no. 7, pp. 889-896, 2006.
75. A.D. Levin, V.Wadhera, S. T. Leach et al., "VitaminDdeficiency in children with inflammatory bowel disease, " DigestiveDiseases and Sciences, vol. 56, no. 3, pp. 830-836, 2011.
76. G.P.Kini, B. Young, P.Herbison, andM. Schultz, "Does seasonal level of serum 25-OH vitamin D correlate with the activity of Crohn's disease?" New Zealand Medical Journal, vol. 127, no. 1394, pp. 51-59, 2014.
77. F. A. Farraye, H. Nimitphong, A. Stucchi et al., "Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease, " Inflammatory Bowel Diseases, vol. 17, no. 10, pp. 2116-2121, 2011.
78. T. A. Sentongo, E. J. Semaeo, N. Stettler, D. A. Piccoli, V. A. Stallings, and B. S. Zemel, "Vitamin D status in children, adolescents, and young adults with Crohn disease, " The American Journal of Clinical Nutrition, vol. 76, no. 5, pp. 1077-1081, 2002.
79. J. S. Siffledeen, K. Siminoski, H. Steinhart, G. Greenberg, and R. N. Fedorak, "The frequency of vitamin D deficiency in adults with Crohn's disease, "Canadian Journal ofGastroenterology, vol. 17, no. 8, pp. 473-478, 2003.
80. H. M. Pappa, E. J. Langereis, R. J. Grand, and C. M. Gordon, "Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease, " Journal of Pediatric Gastroenterology and Nutrition, vol. 53, no. 4, pp. 361-364, 2011.
81. A. N. Ananthakrishnan, A. Cagan, V. S. Gainer et al., "Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease, " Inflammatory Bowel Diseases, vol. 19, no. 9, pp. 1921-1927, 2013.
82. T. Hlavaty, A. Krajcovicova, T. Koller et al., "Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases, " World Journal of Gastroenterology, vol. 20, no. 42, pp. 15787-15796, 2014.
83. L. Peyrin-Biroulet, A. Oussalah, and M.-A. Bigard, "Crohn's disease: the hot hypothesis, " Medical Hypotheses, vol. 73, no. 1, pp. 94-96, 2009.
84. J. R. de Bruyn, R. van Heeckeren, C. Y. Ponsioen et al., "Vitamin D deficiency in Crohn's disease and healthy controls: a prospective case-control study in the Netherlands, " Journal of Crohn's & Colitis, vol. 8, no. 10, pp. 1267-1273, 2014.
85. V. Nerich, P. Jantchou, M.-C. Boutron-Ruault et al., "Low exposure to sunlight is a risk factor for Crohn's disease, " Alimentary Pharmacology and Therapeutics, vol. 33, no. 8, pp. 940-945, 2011.
86. P. Jantchou, F. Clavel-Chapelon, A. Racine, M. Kvaskoff, F. Carbonnel, and M.-C. Boutron-Ruault, "High residential sun exposure is associated with a lowrisk of incident Crohn's disease in the prospective E3N cohort, " Inflammatory Bowel Diseases, vol. 20, no. 1, pp. 75-81, 2014.
87. B. N. Limketkai, T. M. Bayless, S. R. Brant, and S. M. Hutfless, "Lower regional and temporal ultraviolet exposure is associated with increased rates and severity of inflammatory bowel disease hospitalisation, " Alimentary Pharmacology & Therapeutics, vol. 40, no. 5, pp. 508-517, 2014.
88. S.M.Govani, P. D. R. Higgins, R.W. Stidham, S. J.Montain, and A. K.Waljee, "Increased ultraviolet light exposure is associated with reduced risk of inpatient surgery among patients with Crohn's disease, " Journal of Crohn's and Colitis, vol. 9, no. 1, pp. 77-81, 2015.
89. A.N. Ananthakrishnan, H. Khalili, L. M.Higuchi et al., "Higher predicted vitamin D status is associated with reduced risk of crohn's disease, " Gastroenterology, vol. 142, no. 3, pp. 482-489, 2012.
90. M. Garg, O. Rosella, J. S. Lubel, and P. R. Gibson, "Association of circulating vitamin D concentrations with intestinal but not systemic inflammation in inflammatory bowel disease, " Inflammatory Bowel Diseases, vol. 19, no. 12, pp. 2634-2643, 2013.
91. A. N. Ananthakrishnan, A. Cagan, V. S. Gainer et al., "Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases, " Alimentary Pharmacology and Therapeutics, vol. 39, no. 10, pp. 1136-1142, 2014.
92. Z. A. Zator, S. M. Cantu, G. G. Konijeti et al., "Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases, " Journal of Parenteral and EnteralNutrition, vol. 38, no. 3, pp. 385-391, 2014.
93. M. Ham, M. S. Longhi, C. Lahiff, A. Cheifetz, S. Robson, and A. C. Moss, "Vitamin D levels in adults with Crohn's disease are responsive to disease activity and treatment, " Inflammatory Bowel Diseases, vol. 20, no. 5, pp. 856-860, 2014.
94. D. Reid, B. J. Toole, S. Knox et al., "The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitaminDconcentrations after elective knee arthroplasty, "The American Journal of ClinicalNutrition, vol. 93, no. 5, pp. 1006-1011, 2011.
95. J. L. Waldron, H. L. Ashby, M. P. Cornes et al., "Vitamin D: a negative acute phase reactant, " Journal of Clinical Pathology, vol. 66, no. 7, pp. 620-622, 2013.
96. M.T.Cantorna, C.Munsick, C. Bemiss, andB. D.Mahon, "1, 25-Dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease, " Journal of Nutrition, vol. 130, no. 11, pp. 2648-2652, 2000.
97. C. Daniel, H. H. Radeke, N. A. Sartory et al., "The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice, " Journal of Pharmacology and Experimental Therapeutics, vol. 319, no. 2, pp. 622-631, 2006.
98. G. Laverny, G. Penna, S. Vetrano et al., "Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease, " Immunology Letters, vol. 131, no. 1, pp. 49-58, 2010.
99. L. Verlinden, C. Leyssens, I. Beullens et al., "The vitamin D analog TX527 ameliorates disease symptoms in a chemically induced model of inflammatory bowel disease, " The Journal of Steroid Biochemistry and Molecular Biology, vol. 136, no. 1, pp. 107-111, 2013.
100. J. H. Ooi, Y. Li, C. J. Rogers, andM. T. Cantorna, "Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced coliti, " Journal of Nutrition, vol. 143, no. 10, pp. 1679-1686, 2013.
101. A. Assa, L. Vong, L. J. Pinnell et al., "Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury, " Inflammatory Bowel Diseases, vol. 21, no. 2, pp. 297-306, 2015.
102. Q. Tao, B. Wang, Y. Zheng, X. Jiang, Z. Pan, and J. Ren, "Vitamin D prevents the intestinal fibrosis via induction of vitamin D receptor and inhibition of transforming growth factor-beta1/smad3 pathway, " Digestive Diseases and Sciences, 2014.
103. S. Ardizzone, A. Cassinotti, D. Trabattoni et al., "Immunomodulatory effects of 1, 25-dihydroxyvitamin D3 on Th1/Th2 cytokines in inflammatory bowel disease: an in vitro study, " International Journal of Immunopathology and Pharmacology, vol. 22, no. 1, pp. 63-71, 2009.
104. M. Bendix-Struve, L. E. Bartels, J. Agnholt, A. Dige, S. P. Jørgensen, and J. F.Dahlerup, "Vitamin D3 treatment of Crohns disease patients increases stimulated T cell IL-6 production and proliferation, "Alimentary Pharmacology & Therapeutics, vol. 32, no. 11-12, pp. 1364-1372, 2010.
105. M. Stio, M. Martinesi, S. Bruni et al., "The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease, " Journal of Steroid Biochemistry and Molecular Biology, vol. 103, no. 1, pp. 51-60, 2007.
106. L. E. Bartels, M. Bendix, C. L. Hvas et al., "Oral vitamin D3 supplementation reduces monocyte-derived dendritic cellmaturation and cytokine production in Crohn's disease patients, " Inflammopharmacology, vol. 22, no. 2, pp. 95-103, 2014.
107. P. Miheller, G. Muzes, I. Hritz et al., "Comparison of the effects of 1, 25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients, " Inflammatory BowelDiseases, vol. 15, no. 11, pp. 1656-1662, 2009.
108. S. P. Jørgensen, J. Agnholt, H. Glerup et al., "Clinical trial: vitamin D3 treatment in Crohn's disease-a randomized doubleblind placebo-controlled study, " Alimentary Pharmacology and Therapeutics, vol. 32, no. 3, pp. 377-383, 2010.
109. L. Yang, V. Weaver, J. P. Smith, S. Bingaman, T. J. Hartman, and M. T. Cantorna, "Therapeutic effect of vitamin D supplementation in a pilot study of Crohn's patients, " Clinical and Translational Gastroenterology, vol. 4, article e33, 2013.